Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

Clinical trial NCT00847301 · COMPLETED

Trial details

NCT number: NCT00847301
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Arthroplasty, Replacement Thromboembolism

Start date: 2009-04-01
Primary completion: 2014-07-01
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.